Who is sponsoring NCT03095313?

NCT03095313 is sponsored by Cedars-Sinai Medical Center.

What condition does NCT03095313 study?

NCT03095313 studies Aortic Stenosis.

What is the status of NCT03095313?

NCT03095313 is currently COMPLETED.

Last reviewed 2025-02-12 · How we verify

18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes

NCT03095313 PHASE2 COMPLETED

This is a pilot study in which we will aim to demonstrate successful execution of the imaging protocol and to make observations regarding the calcification activity as measured by 18F-NaF PET/CT and any correlation to 1) valve age and valve type, and 2) subsequent degeneration of aortic valve bioprostheses based upon clinical, echocardiographic and CT parameters. Additionally, the data will serve as preliminary data to plan a larger study to investigate study objectives.

Details

Lead sponsor	Cedars-Sinai Medical Center
Phase	PHASE2
Status	COMPLETED
Enrolment	20
Start date	Sun Jul 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Feb 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Aortic Stenosis

Interventions

18F-NaF

Countries

United States